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Abstract
Background: In Australia, bowel cancer screening participation using faecal occult blood testing (FOBT) is low.
Decision support tailored to psychological predictors of participation may increase screening. The study compared
tailored computerised decision support to non-tailored computer or paper information. The primary outcome was
FOBT return within 12 weeks. Additional analyses were conducted on movement in decision to screen and change
on psychological variables.
Methods: A parallel, randomised controlled, trial invited 25,511 people aged 50–74 years to complete an eligibility
questionnaire. Eligible respondents (n = 3,408) were assigned to Tailored Personalised Decision Support (TPDS),
Non-Tailored PDS (NTPDS), or Control (CG) (intention-to-treat, ITT sample). TPDS and NTPDS groups completed an
on-line baseline survey (BS) and accessed generic information. The TPDS group additionally received a tailored
intervention. CG participants completed a paper BS only. Those completing the BS (n = 2270) were mailed an FOBT
and requested to complete an endpoint survey (ES) that re-measured BS variables (per-protocol, PP sample).
Results: FOBT return: In the ITT sample, there was no significant difference between any group (χ2(2) = 2.57, p = .26;
TPDS, 32.5%; NTPDS, 33%; and CG, 34.5%). In the PP sample, FOBT return in the internet groups was significantly
higher than the paper group (χ2(2) = 17.01, p < .001; TPDS, 80%; NTPDS, 83%; and CG, 74%). FOBT completion by
TPDS and NTPDS did not differ (χ2(1) = 2.23, p = .13). Age was positively associated with kit return.
Decision to screen: 2227/2270 of the PP sample provided complete BS data. Participants not wanting to screen at
baseline (1083/2227) and allocated to TPDS and NTPDS were significantly more likely to decide to screen and
return an FOBT than those assigned to the CG. FOBT return by TPDS and NTPDS did not differ from one another
(OR = 1.16, p = .42).
Change on psychosocial predictors: Analysis of change indicated that salience and coherence of screening and
self-efficacy were improved and faecal aversion decreased by tailored messaging.
(Continued on next page)
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Conclusions: Online information resources may have a role in encouraging internet-enabled people who are
uncommitted to screening to change their attitudes, perceptions and behaviour.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12610000095066
Keywords: Randomised controlled trial, Decision support, Bowel cancer, Faecal occult blood test, Cancer
screening, Tailored messages
Background
In 2012 bowel (colorectal) cancer was the second most
commonly diagnosed cancer in Australia for both men
and women, and it was the third most common cause of
cancer-related mortality in 2010 [1]. Participation in bowel
cancer screening using a faecal occult blood test (FOBT)
in accordance with recommended guidelines reduces
bowel cancer mortality [2-4] and potentially incidence,
although lowered incidence rates from use of FOBT
alone has not been absolutely demonstrated [5,6]. Data
on screening participation in Phase 2 of the Australian
government-funded National Bowel Cancer Screening
Program (NBCSP), which operated between July 1 2008
and June 30 2011, and provided free screening with an
FOBT to people turning 50, 55 and 65 years, indicate
sub-optimal uptake rates of 34.0%, 38.8% and 46.9% re-
spectively [7]. Low participation rates in bowel cancer
screening are widely reported and consistently evident
across programs with different screening modes (e.g.,
colonoscopy and flexible sigmoidoscopy) and in different
geographic locations [8-11].
Decision aids have been developed to assist consumers
to optimise health-related decision making, including
screening. These include written and audio materials, as
well as interactive web-based tools. A recent systematic
review has concluded that decision aids improve partici-
pants’ knowledge of the options available and perceptions
that decision-making is informed [12].
Some evidence suggests that tailoring health informa-
tion used in decision aids to the needs of the individual
may facilitate desired changes in intention and behaviour,
including cancer screening. Rimer and Kreuter [13] de-
fined tailored health communication as “any combination
of information and behaviour change strategies intended
to reach one specific person based on information unique
to that person, related to the outcome of interest, and de-
rived from an individual assessment” (p. S184). A meta-
analytic review of 56 tailored print health behaviour
change interventions [14] reported a sample-weighted
mean effect size of r = .074 (95% CI .066, .082). Although
this can be characterised as approaching a small effect
size, the impact of tailoring was largely moderated by
demographic and behavioural variables and methodo-
logical features of the study. Importantly, the following
were included among the variables that predicted a larger
effect size; a focus on preventive or screening behaviour,
recruiting participants from the household rather than an
organisation, focusing tailoring on demographics and 4 or
more theoretical concepts that predict behaviour, and
using a social cognitive theory or stages of change model,
or both, to guide tailoring.
Computer-based tailoring provides increased opportun-
ity to deliver personal, tailored messages in a flexible,
novel, timely and economically feasible manner [15]. A re-
cent meta-analysis by Krebs, Prochaska and Rossi [16]
confirmed that tailoring achieved benefits when informa-
tion was delivered by computer. The study included 88
interventions that examined the impact of computer
tailoring on smoking, physical activity, healthy eating and
regular attendance at mammography. All four behaviours
were positively impacted by computer-based tailoring with
mammography adherence enhanced by 6% over the con-
trol condition. Although these results appear promising
they failed to identify the nature of the information to be
tailored, or the theories that might guide identification of
the appropriate variables.
Albada, Ausems, Bensing, and van Dulmen [17] under-
took a systematic review that assessed the impact of
tailoring information about cancer risk and screening,
concluding that more evidence was required before a
positive impact from tailoring could be assumed. More-
over, the two studies included that examined FOBT use
found only limited evidence of a beneficial effect from
tailoring [18]. Consistent with this result, a recent attempt
at establishing the efficacy of tailoring for people consider-
ing bowel cancer screening has had only limited success.
Vernon et al. [19] undertook a randomised, controlled trial
of a tailored, interactive intervention designed to enhance
participation in a patient-selected bowel cancer screening
option. In this study, messages received by the tailored on-
line intervention group were determined by matching
“process of change” feedback to the individual’s current
stage of readiness to screen and preferred screening ap-
proach. Processes of change (e.g., “consciousness raising”
as a process to move an individual from precontemplation
to contemplation; see Prochaska, Redding & Evers
[20]) were, in turn, mapped to hypothesised determinants
(e.g., knowledge of the various forms of screening for
bowel cancer) and a behaviour change technique [21]. Al-
though exposure to the intervention material improved
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knowledge and self-efficacy for screening, these improve-
ments did not lead to improved participation rates.
Although disappointing, these results may reflect tailor-
ing on suboptimal variables. Myers et al. [22] tested both
targeted (at those who were overdue for screening) and tai-
lored invitations (messages that addressed personal barriers
to screening) to increase screening participation. Tailored
messages were developed on the basis of previously ob-
tained scores on Preventive Health Model (PHM) variables
(i.e., salience and coherence of screening, perceived suscep-
tibility to bowel cancer, cancer worries and concerns, self-
efficacy for screening, response efficacy for screening and
perceived social support for screening) and matched to the
individual’s decision stage for a stool blood test or a flexible
sigmoidoscopy. Increased screening participation of be-
tween 11 and 15% was achieved for targeted and tailored
interventions over usual care controls.
These promising results, together with the demonstrated
positive effect of computer-based tailoring [16], encouraged
us to develop an internet-based, tailored, Personalised Deci-
sion Support (PDS) tool for bowel cancer screening. Tailor-
ing was based on the utilisation of individual responses to
the PHM variables, previously validated for use in Australia
[23], and their relationship to stage of readiness to screen
in a manner directly comparable to Myers et al. [22]. An
exploratory study to investigate the effectiveness of the
PDS, whilst lacking statistical power, indicated the potential
to positively address attitudes toward screening [24].
The protocol [25] for the current trial was developed
after completion of the exploratory study. The aim was
to compare the impact of communication materials
tailored in real time and delivered over the internet to
non-tailored material received in the same manner and
mailed, non-tailored material (the latter approach being
usual care for population screening in Australia). This
design enabled us to investigate the contribution of
message delivery mode (computer versus paper) and
personal relevance of information (tailoring versus non-
tailoring) or both, on participation. The primary hypoth-
esis was that the internet-tailored information group
would demonstrate higher return rates of FOBT com-
pared to both internet and mailed non-tailored informa-
tion groups. The secondary hypothesis was that internet-
tailored information group would be at a higher stage of
readiness to participate after the intervention and demon-
strate greater improvements on PHM variables targeted on
the basis of stage of readiness at baseline, and tailored
according to need for motivation or reinforcement, also
determined by responses at baseline, than participants in
the other two groups.
Methods
The methods described below summarise those in the
published protocol [25] with the exception of two
aspects. Firstly, the final sample size approached to
recruit sufficient eligible persons was higher than that
envisaged (~25,000 compared to the forecast of 18,000)
due primarily to non-return of surveys and ineligibility
arising because of recent participation in screening or
endoscopic examination. Secondly, the protocol indi-
cated that a secondary outcome of decisional conflict
and satisfaction scores would be reported in addition to
change on psychological variables. In the event, given
the length and breadth of the current article, it was
decided that these conflict and satisfaction outcomes
should constitute a separate, future report.
Study design and setting
Ethical approval for the study was obtained from the
Commonwealth Scientific and Industrial Organisation
Human Research Ethics Committee (09/33). The study
was a parallel, randomised, controlled trial, stratified by
sex and population density at the Australian state level
and conducted in Australia from 2010 to 2012. A
randomly-selected sample of men and women aged
between 50 and 74 years from every mainland state who
resided in urban electoral divisions was obtained from
the Australian Electoral Commission roll. Electors
whose addresses indicated that they were likely to be
living in assisted accommodation (for example, an aged
care hostel facility) were excluded from possible selec-
tion. Only one member from each household was
included in the final sample to avoid possible cross-
contamination between the groups. The family member
retained was the one whose details came first in the
supplied randomised list. The trial proceeded through a
number of phases (Table 1). These are described in
detail in the published study protocol [25] and sum-
marised below.
Intervention phases
Phase 1: eligibility and randomisation
Following exclusion of those living in assisted accommo-
dation or living in the same household as a previously
selected elector, individuals remaining in the sample
(n = 25,511) were mailed an introductory letter, an infor-
mation sheet outlining the study, a short eligibility
questionnaire (EQ) and a pre-paid return envelope. This
sample was reduced to n = 25,057 after exclusions
(Figure 1). The EQ addressed the inclusion criteria (aged
50 to 74 years inclusive; access to the internet) and
exclusion criteria (FOBT screening within the previous
12 months; sigmoidoscopy or colonoscopy within the
previous 5 years; clinical diagnosis of bowel cancer).
Other data collected were demographic (employment
status, education level), whether the internet was used
to search for health-related information, willingness to
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receive unsolicited health information via the internet
and source of internet access. The opportunity to win 1
of 3 $200 grocery-shopping vouchers was offered as an
incentive to complete and return the questionnaire.
Recipients were able to formally opt out of further
correspondence at this stage. Return of the completed
EQ was regarded as informed consent and willingness
to participate in the trial, if eligible. Non-respondents
were sent reminders at 4 and 6 weeks.
People meeting the eligibility criteria were stratified
at the individual Australian state level and block-
randomised using random allocation software [26]
to one of 3 trial groups: internet-delivered Tailored
Personalised Decision Support (TPDS) or Non-Tailored
Personalised Decision Support (NTPDS), or a non-
tailored, mail-delivered Control Group (CG). This
sample provided the basis for the examination of treat-
ment effects on screening participation using Intention-
to-Treat analysis and is defined throughout as the ITT
sample. Whereas investigators were aware of allocation
status, participants and outcome assessors were kept
blinded. Thereafter participants proceeded through a
number of stages (Table 1) according to allocation, as
described below.
Phase 2: Intervention
Two weeks following return of the eligibility question-
naire by the invitees, eligible participants were con-
tacted. They were reminded that they could opt out at
each point of contact with the project team. Those
allocated to the TPDS and NTPDS groups were asked to
access a website using a uniquely-allocated username
and password. After logging in participants in both
groups completed an on-line Baseline Survey (BS)
that collected additional demographic data; Precaution
Adoption Process Model (PAPM) decision stage [27];
Preventive Health Model (PHM) and self-efficacy vari-
able scores, and a measure of faecal aversion (measures
are summarised in Table 2). CG participants were mailed
a paper BS, which they were asked to complete and
return.
Participants who returned the BS within 12 weeks
defined the sample utilised in the modelling of the link be-
tween psychological variables and screening participation.
They are defined throughout as the Per Protocol sample
(Figure 1).
The internet Tailored PDS (TPDS) group participants
received messages about screening designed to either
motivate a change in attitude, where this was not con-
sistent with screening participation, or reinforce existing
attitudes, where these were consistent. Messages pertain-
ing to each PHM variable were presented in an order
that accorded with the results of previous research. This
prior research had demonstrated that addressing a
specific subset of PHM variables at specific stages was
associated with movement to a higher stage of readiness
to screen as measured by the PAPM [28-30]. In our
study the two PHM variables that Myers and colleagues
[28] established were most strongly linked to movement
between specific PAPM decision stages were given prior-
ity and presented as the first two motivating and/or
reinforcing messages. The aim of message order place-
ment was to exploit the primacy effect whereby informa-
tion that is important for medical decision-making is
presented first in order to ameliorate problems with
short term memory [31]. The construction and delivery
of the tailored messages has been described previously
in greater detail [24]. In addition to receiving these
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bThese results published [33].
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tailored messages, participants had an opportunity to
view an on-line version of the National Bowel Cancer
Screening Program (NBCSP) consumer information
booklet [32].
The internet Non-Tailored PDS (NTPDS) participants
did not receive any tailored messages in response to the
BS; they were offered access to the on-line NBCSP con-
sumer information booklet only. Control Group (CG)
participants were mailed an information sheet and a
printed BS, which they were requested to complete and
return in a supplied, pre-paid envelope. Consistent with
usual care, the CG participants received an information
booklet with the FOBT.
All participants were mailed an FOBT and associated
materials two weeks following completion of the BS. The
screening package consisted of: (a) two-sample FOBT
(immunochemical FOBT, OC Sensor, Eiken Chemical Co.
Ltd, Tokyo, Japan) with instructions, two sample collec-
tion sheets and a reply paid envelope; (b) a Participant
Details form to confirm personal details and nominate
a preferred doctor, with a simple section for participants
to provide signed consent to obtain clinical follow-up re-
ports if required. A research-scale bowel screening facility
(Bowel Health Service) provided all FOBTs, test develop-
ment and reporting services. CG participants received a
printed version of the NBCSP consumer information
Figure 1 CONSORT flow diagrama. *The intention-to-treat analyses included all eligible participants who responded to the Eligibility Questionnaire
and were randomised to a group regardless of further participation. In the Per Protocol analyses, we only included participants who completed a baseline
survey and were mailed an FOBT. The PHM variable change sample constituted participants who completed an endpoint survey and contributed to
analyses of change in baseline PHM variable scores following exposure to group allocation. a N = 63 participants, representing the 3 study
arms and consisting of those who had both returned and not returned an FOBT, continued to a qualitative phase [33].
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booklet and those in the intervention groups were
reminded that they could return to the website and revisit
their tailored messages and the NBCSP information booklet
(tailored PDS group); or the NBCSP information booklet
only (non-tailored PDS group). The Bowel Health Service,
unaware of group allocation, analysed the returned samples
and informed the participant if the result was negative.
Where a positive result was found, both the participant and
their nominated doctor were informed and assisted if re-
quested with clinical follow-up. A postal reminder was sent
to those who did not return their completed FOBT within
6 weeks of despatch. Individual FOBT return data were
relayed to the investigators as ID only.
Phase 3: evaluation
Participants were contacted by letter 1 to 2 weeks after
receipt of their FOBT, or 12 weeks following the invita-
tion to screen if an FOBT was not returned. They were
asked to complete the Endpoint Survey (ES), either by
returning to the online site (intervention groups) or
completing the accompanying ES in paper format (con-
trol group). The ES re-measured PHM/PAPM variables
and collected additional information relating to outcome
measures. Return of the ES determined a participant’s
eligibility for inclusion in analyses examining the impact
of changes on psycho-social variables on participation in
screening. This group has been termed the PHM vari-
able change sample (Figure 1).
Phase 3 also encompassed a qualitative exploration
of decision-making around bowel cancer screening. A
series of focus groups and individual telephone inter-
views were conducted with n = 63 participants repre-
senting the 3 study arms, who had both returned and
not returned an FOBT. The interviews revolved around
the participants’ reasons for their decision to screen or not
to screen. A description of the conduct and findings of
this qualitative component has previously been pub-
lished [33] and will not be addressed further in this
paper.
Materials
An overview of the materials developed for the study
follows. A more detailed explanation of how the Baseline
Survey (BS) component was utilised in conjunction with
the message library has previously been published [24].
Surveys
The baseline and endpoint surveys contained a series of
statements reflecting Preventive Health Model (PHM)
[34,35], self-efficacy and faecal aversion variables. Self-
efficacy and faecal aversion were measured using state-
ments derived from previous research regarding FOBT
use [34,36]. These statements are provided in Table 2.
All responses were measured on a 5-point Likert scale
ranging from “strongly disagree” to “strongly agree”. The
user’s stage of decision to screen as measured by the
Precaution Adoption Process Model (PAPM, Table 2) was
also ascertained in both surveys.
Table 2 PHM, self-efficacy and faecal aversion variables;
PAPM decision stages
PAPM decision stages for FOBT screening:






Having colorectal cancer screening is an important
thing for me to dob
Colorectal cancer screening makes sense to me
Having colorectal cancer screening can help to
protect my health
I will be just as healthy if I avoid having colorectal
cancer screeningc
Social Influence Members of my immediate family think I should
have colorectal cancer screeningb
I want to do what members of my immediate family
think I should do about colorectal cancer screening
My doctor or health professional thinks I should
have colorectal cancer screening
I want to do what my doctor or health professional
thinks I should do about colorectal cancer screening
Cancer Worries I am afraid of having an abnormal colorectal cancer
screening test result
I am worried that colorectal cancer screening will
show that I have colorectal cancer
Perceived
Susceptibility
Compared with other persons my age, I am at lower
risk for colorectal cancerc
The chance that I might develop colorectal cancer is
high
The chances that I will develop colorectal polyps are
highb
Response Efficacy When colorectal polyps are found and removed,
colorectal cancer can be preventedb
When colorectal cancer is found early, it can be
cured
Self-efficacy I think that doing the test would be easy for meb
Finding time to do the test would be difficult for
mec
Completing the test correctly would be easy for me
Faecal Aversion Collecting faeces for the purpose of bowel cancer
screening is distastefulb,c
Collecting faeces for the purpose of bowel cancer
screening is unhygienicc
Giving a sample of faeces to another person is
embarrassingc
aPreventive Health Model (PHM) items reproduced from Tiro et al. [35].
bStatements used for tailored assessment.
cItems were reverse coded.
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NBCSP consumer information booklet
An electronic version of the NBCSP’s consumer infor-
mation booklet [32] was developed. It provided the same
information as that contained in the paper version save
for information regarding how to opt off or suspend
from the impending screening offer.
Tailored internet intervention
Content received by the tailored group were the baseline
and endpoint surveys for completion; a message library
tailored to the individual user’s decision stage for screen-
ing and responses to PHM, self-efficacy and faecal aver-
sion variables contained in the baseline survey, and
access to an electronic version of the NBCSP consumer
information booklet.
Non-tailored internet and paper interventions
Materials for the non-tailored internet and paper groups
were the baseline and endpoint surveys for completion
and access to the NBCSP consumer information booklet
(electronic or paper versions as appropriate).
Statistical analysis
Sample size and power considerations
Sample size and power calculations were based on the
numbers needed to test the primary hypothesised differ-
ence in participation between groups. A-priori calcula-
tions determined n =1080 participants per treatment
group provided sufficient power (α = .05, β = .80) for a
Chi-squared test to detect a difference of at least 10%
between any two groups assuming a participation rate
of 40% in the control group. Thus, the final number of
n ≥1135 per treatment arm surpassed the requirements
for adequate power.
Statistical analyses
Data analysis was completed during 2014. Comparison
of participation data between the three groups was per-
formed at the Intention-to-Treat randomisation level
(ITT Sample). Separate analyses were also undertaken
on those participants who returned the baseline survey
(Per Protocol Sample; n = 2270) in order to examine the
impact of psychosocial factors on FOBT uptake. Univari-
ate binomial Generalized Linear Models (GLMs) were
conducted to assess the impact of the intervention on
FOBT return in both the ITT Sample and Per Protocol
Sample. The impact of the intervention was assessed by
coding treatment arms according to two, two-level fac-
tors (internet vs. paper and tailored vs. non-tailored) in
order to model main effects and an interaction. GLMs
were then conducted that included all demographics
and, for the Per Protocol Sample, scores for psychosocial
constructs measured at baseline that were found to pre-
dict FOBT return in univariate models at the two-tailed
p < .05 level. GLMs were also used to assess the impact
of the intervention on FOBT uptake in participants dis-
tal to screening at baseline. As a secondary analysis, we
examined change in the psychosocial variables over time.
Change scores were calculated by subtracting baseline
from endpoint scores in individuals who completed an
endpoint survey (PHM variable change sample). Factor-
ial ANOVAs were then used to assess the impact of trial




Approximately 35% of people (8,762 of 25,057) returned
the Eligibility Questionnaire (EQ). Of the respondents,
significantly more: were from South Australia and Western
Australia compared to New South Wales and Victoria
(p = <.001); were from 60:64 and 65:69 age groups com-
pared to the 50:54 group (p = <.001); and were female
(p = <.001). Of the n = 8,762 who returned the com-
pleted EQ, n = 3,408 were identified as eligible (38%;
13.4% of those initially approached), randomised to
intervention arms and defined the ITT sample: internet
Tailored PDS (TPDS, n = 1137), internet Non-Tailored
PDS (NTPDS, n = 1136) and paper-based non-tailored
Control Group (CG, n = 1135). There was no significant
difference between these groups in use of the internet
to search for health information (p = .36) or willingness
to receive unsolicited health information via the Internet
(p = .62). A more detailed discussion of these latter results
has previously been published [37]. All individuals in the
ITT sample were mailed a Baseline Survey (BS) in order to
progress to a screening offer. Of these individuals, 20
(<1%) BS packages were returned to sender, 250 (7%)
opted out of further participation, 13 (<1%) returned a
blank or significantly incomplete questionnaire, 855 (25%)
did not return a survey or contact the researchers, and
2,270 (66%) returned a BS and formed the Per Protocol
sample for further analyses.
Group characteristics were compared in each of the
ITT and Per Protocol samples. As shown in Table 3, the
groups were relatively homogenous with regards to
demographics. Overall, the groups were mostly com-
prised of individuals aged 65 years and under and the
proportion of males to females was relatively equal. Ac-
cording to the Socio-Economic Indexes for Areas
(SEIFA) Index of Relative Socio-economic Advantage
and Disadvantage Deciles [38], participants were mostly
from a background with higher advantage indices.
Intervention effect on FOBT return
For the ITT sample, all individuals who did not return a
FOBT, or who were not offered a FOBT for the reasons
described previously, were regarded as non-participants.
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Overall screening participation rates were: internet tai-
lored PDS (32.5%); internet non-tailored PDS (33%); and
CG (34.5%). In the initial binomial GLM, treatment arm
only was included as a predictor of screening participa-
tion and there was no significant effect of treatment arm
on screening uptake as indicated by the overall test of
model effects (χ2(2) = 2.57, p = .26). In a subsequent
model we included demographics and, in this case, the
overall model effects were significant (χ2(12) = 80.91,
p = <.001; Table 4). Examination of model results indi-
cates that age group had an effect on participation,
with screening rates increasing with increasing age.
Location differences were also evident with New South
Wales residents less likely than Western Australia resi-
dents to return an FOBT.
The same process as above was followed for the analysis
of data from only those who returned a Baseline Survey,
i.e. the Per Protocol Sample. Participation rates in this
sample were as follows: internet tailored PDS (TPDS),
80%; internet non-tailored PDS (NTPDS), 83%; and paper-
based control group (CG), 74%. In contrast to the ITT
data analysis, an initial univariate model of the effect of
the intervention on FOBT return showed a significant
effect for the model overall (χ2(2) = 17.01, p < .001);
screening participation in the internet groups (TPDS and
NTPDS) was significantly higher than for the paper group
(CG). A subsequent 2x2 chi-square comparing TPDS and
NTPDS conditions showed these groups did not differ
from one another (χ2(1) = 2.23, p = .13). A subsequent
GLM model including all demographics was also
Table 3 Demographic characteristics of ITT and per protocol samples
Control Non-tailored tailored
n % n % n %
ITT Sample AGE 50–54 348 30.7% 330 29.0% 331 29.1%
55–59 302 26.6% 298 26.2% 315 27.7%
60–64 266 23.4% 296 26.1% 275 24.2%
65–69 126 11.1% 123 10.8% 142 12.5%
70–74 93 8.2% 89 7.8% 74 6.5%
SEX Male 557 49.1% 556 48.9% 559 49.2%
Female 578 50.9% 580 51.1% 578 50.8%
SEIFA* SEI_AD <5 173 15.2% 173 15.2% 190 16.7%
SEI_AD >5 962 84.8% 963 84.8% 947 83.3%
STATE NSW 219 19.3% 220 19.4% 220 19.3%
QLD 214 18.9% 214 18.8% 215 18.9%
SA 242 21.3% 242 21.3% 241 21.2%
VIC 210 18.5% 209 18.4% 210 18.5%
WA 250 22.0% 251 22.1% 251 22.1%
Per Protocol Sample AGE 50–54 238 28.9% 207 28.9% 205 28.0%
55–59 220 26.7% 187 26.1% 200 27.4%
60–64 195 23.7% 177 24.7% 184 25.2%
65–69 100 12.2% 85 11.9% 90 12.3%
70–74 70 8.5% 60 8.4% 52 7.1%
SEX Male 413 50.2% 368 51.4% 371 50.8%
Female 410 49.8% 348 48.6% 360 49.2%
SEIFA* SEI_AD <5 128 15.6% 97 13.5% 111 15.2%
SEI_AD >5 695 84.4% 619 86.5% 620 84.8%
STATE NSW 154 18.7% 128 17.9% 123 16.8%
QLD 162 19.7% 148 20.7% 139 19.0%
SA 178 21.6% 151 21.1% 162 22.2%
VIC 151 18.3% 129 18.0% 128 17.5%
WA 178 21.6% 160 22.3% 179 24.5%
*SEIFA: <5 = higher disadvantage and lower advantage; >5 = lower disadvantage and higher advantage.
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significant overall (χ2(12) = 105.95, p < .001) and results
are presented in Table 5. In this model, there were signifi-
cant effects for treatment arm, sex, and age group. Con-
sistent with the ITT analysis, increasing age was associated
positively, although not linearly, to participation. Addition-
ally, female gender was associated with FOBT return.
Psychosocial variables and FOBT return
In order to determine which psychosocial variables
measured at baseline were associated with FOBT return,
univariate GLMs were conducted with screening participa-
tion as the outcome variable. Descriptive statistics for psy-
chosocial variables measured in the Baseline Survey (BS)
are provided in Table 6. Salience & coherence, self-efficacy,
faecal aversion and social influence were all significant
univariate predictors (all p < .01), whereas cancer worries,
perceived susceptibility and response efficacy did not pre-
dict FOBT return. A subsequent multivariate GLM was
conducted that included treatment condition, the four
significant psychosocial predictors, and demographic
variables. This model was significant (χ2(12) =131.74,
p < .001), but of the four psychosocial factors only self-
efficacy remained statistically significant. Moreover,
SEIFA did not contribute to the model and thus, the
final model was revised again and is presented as
Table 7. Higher levels of self-efficacy at baseline were
strongly predictive of screening uptake and the effects
of demographic variables remained consistent with the
models presented previously. Treatment effects were
also significant and consistent.
Impact of intervention on participants uncertain about
screening at baseline
It was hypothesized that the tailored intervention would
improve decision stage more than the non-tailored ap-
proach. Ninety-eight percent of the Per Protocol Sample
(2227/2270) provided complete data regarding their
baseline decision stage and the distribution of individ-
uals across these stages is provided in Table 8. About
15% of participants had never heard of screening for
bowel cancer and about 28% had heard of screening but
were not currently considering screening. However, the
majority of participants in all conditions wanted to screen
at study commencement (n = 1144/2227, or 51.4%). This
is particularly relevant to the current trial, given that
Table 4 Multivariate GLM of predictors of FOBT return











Control Tailored 0.87 0.11 0.74 1.03
Non-tailored 0.90 0.22 0.76 1.06
Female Male 1.05 0.51 0.91 1.20
SEIFA - LOWER SEIFA - HIGHER 1.16 0.14 0.95 1.41
Age 50–54 years 55-59 1.29 0.01 1.08 1.54
60-64 1.67 0.00 1.39 2.01
65-69 1.75 0.00 1.38 2.22
70-74 1.97 0.00 1.49 2.62
WA NSW 0.73 0.00 0.59 0.90
QLD 1.13 0.25 0.92 1.40
SA 1.19 0.11 0.96 1.48
VIC 0.84 0.11 0.68 1.04
Table 5 Multivariate GLM of predictors of FOBT return











Control Tailored 1.36 0.01 1.07 1.74
Non-tailored 1.69 0.00 1.31 2.18
Female Male 0.81 0.04 0.65 0.99
SEIFA - LOWER SEIFA - HIGHER 0.94 0.71 0.69 1.29
Age 50–54 years 55-59 1.53 0.00 1.19 1.98
60-64 3.06 0.00 2.26 4.14
65-69 2.22 0.00 1.55 3.18
70-74 3.07 0.00 1.93 4.88
WA NSW 0.81 0.20 0.60 1.11
QLD 1.18 0.32 0.85 1.63
SA 1.38 0.06 0.99 1.93
VIC 0.86 0.35 0.63 1.18
Table 6 Descriptive statistics for baseline psychosocial




Salience & Coherence Mean 4.31 4.29 4.24 4.28
SD 0.53 0.57 0.55 0.55
Cancer Worries Mean 2.80 2.90 2.85 2.85
SD 1.02 0.98 1.00 1.00
Perceived Susceptibility Mean 2.80 2.89 2.82 2.83
SD 0.54 0.57 0.53 0.55
Response Efficacy Mean 3.72 3.78 3.74 3.75
SD 0.59 0.53 0.55 0.56
Self-Efficacy Mean 3.96 3.97 3.96 3.96
SD 0.62 0.55 0.55 0.57
Faecal Aversion Mean 2.43 2.45 2.46 2.45
SD 0.86 0.84 0.81 0.84
Social Influence Mean 3.48 3.68 3.63 3.59
SD 0.75 0.68 0.66 0.70
Note: Correlations between variables were low, demonstrating relative
independence: Mean r =0.11, Min r =0.01, Max r =0.30.
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tailoring is concerned primarily with moving individuals
who are not yet ready to screen towards actual screening
behaviour rather than having an impact on those people
who are already prepared to screen. To further explore the
impact of tailoring on FOBT return, participants who
already ‘want to screen’ were excluded (total n remaining
for analysis = 1083/2227; TPDS = 351; NTPDS = 344;
CG = 388) and a GLM was conducted in which trial con-
dition in those not yet ready to screen was used to predict
FOBT return. In addition to trial allocation, significant
psychosocial predictors of screening in these individuals
were identified through an iterative univariate and multi-
variate process and the final model is shown as Table 9.
Results indicated that participants who were not ready to
screen, and allocated to the internet PDS (tailored or not)
were significantly more likely to complete an FOBT than
those assigned to the paper-based control condition.
FOBT return rates across all conditions in these individ-
uals was as follows: TPDS 80% (279/351); NTPDS 82%;
(282/344); CG, 70% (272/388).
Further examination of this model showed that the two
internet arms did not differ significantly from one another
with regards to screening participation (compared to tai-
lored PDS, non-tailored PDS OR = 1.16, p = .42). In this
sample, salience and coherence and perceived susceptibil-
ity, measured at baseline, predicted screening uptake. This
result was not observed in previous analyses that included
the Per Protocol Sample (see Table 7). The direction of the
effect was as expected for salience & coherence, with
higher scores associated with uptake, but it was opposite
to what was found for perceived susceptibility; lower
perceived susceptibility was associated with screening
participation. Self-efficacy was again a significant predictor
of screening participation in the expected direction, con-
sistent with earlier analyses.
Change on psychosocial variables
The hypothesis that scores on Preventive Health Model
(PHM) variables would change following exposure to the
intervention differentially according to group allocation
was tested. All of those who completed the baseline sur-
vey (Per Protocol sample) were asked to complete the
endpoint survey, and 80% did so (total n = 1,825/2270;
internet tailored PDS 80% (586/731); internet non-
tailored TPDS 83% (592/716); paper-based CG 79%
(647/823). Baseline and endpoint scores for this sample
are shown in Table 10. In order to explore change on
these variables, change scores were calculated by subtract-
ing baseline scores from endpoint scores. Using univariate
ANOVAs, change scores were entered as the dependent
variable and the effects of the independent variables
Treatment Group (TPDS, NTPDS, CG) and FOBT return
(Yes, No) and the interaction term (Treatment Group X
FOBT return) examined.
Table 8 Distribution of individuals across decision stages
at baseline




Never Heard Of Screening 141 105 88 334
18.1% 14.7% 12.0% 15.0%
Heard But Not Considered
Screening
195 198 227 620
25.0% 27.7% 31.1% 27.8%
Does not Want to Screen 7 3 2 12
.9% .4% .3% .5%
Unsure About Screening 45 38 34 117
5.8% 5.3% 4.7% 5.3%
Wants to Screen 392 372 380 1144
50.3% 52.0% 52.0% 51.4%
TOTAL 780 716 731 2227
100%
Table 7 Multivariate GLM of predictors of FOBT return for












Control Tailored 1.37 0.01 1.07 1.76
Non-tailored 1.68 0.00 1.30 2.17
Female Male 0.77 0.02 0.63 0.96
Age 50–54 years 55-59 1.49 0.00 1.15 1.93
60-64 3.03 0.00 2.23 4.10
65-69 2.09 0.00 1.45 3.01
70-74 3.09 0.00 1.93 4.92
WA NSW 0.81 0.20 0.59 1.12
QLD 1.19 0.30 0.86 1.65
SA 1.41 0.04 1.02 1.96
VIC 0.86 0.34 0.62 1.18
Self-Efficacy N/A 1.73 0.00 1.45 2.07
Table 9 Impact of intervention and psychological
variables on FOBT return of participants (n = 1083) not









Control Non-Tailored 1.91 .001 1.276 2.621
Tailored 1.64 .012 1.106 2.219
Salience & Coherence N/A 1.38 .022 1.049 1.845
Perceived Susceptibility N/A .67 .006 .498 .891
Self-Efficacy N/A 1.61 .000 1.264 2.128
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Results indicated that there was no effect of Treatment
Group or FOBT return on amount of change in perceived
susceptibility, response efficacy or social influence (all
p > .14). For cancer worries there was a main effect (F
(1,1819) = 8.17, p < .01, η2 = .004) for FOBT return only.
Non screening participants showed an increase (M = 0.16,
95% CI [0.01, 0.31]) whilst screeners showed a decrease in
cancer worries (M = −0.07, 95% CI [−0.02, −0.11]).
There were Treatment Group effects for salience & co-
herence (F(2,1819) = 5.59, p = .004, η2 = .01) and faecal
aversion (F(2,1819) = 7.55, p = .001, η2 = .01). Perceptions
about the salience & coherence of screening improved
most in the tailored intervention group, followed by the
non-tailored intervention group, and finally the control
group. Specifically, Bonferroni post-hoc comparisons re-
vealed a significant difference (p < .001) between the aver-
age change scores of the internet tailored PDS (M = 0.12,
95% CI [0.08, 0.17]) versus CG conditions (M = 0.01, 95%
CI [−0.03, 0.04]), and also (p = .03) between internet
tailored and non-tailored PDS groups (M = 0.05, 95%
CI [0.00, 0.09]). The difference between the CG and
non-tailored PDS was not significant (p = .65).
People in the tailored PDS group also showed greater
declines in faecal aversion than the other two groups
with a significant difference (p < .001) observed between
tailored PDS (M = −0.37, 95% CI [−0.31, 0.42]) and CG
conditions (M = −0.18, 95% CI [−0.12, −0.23]), but not
(p = .12) between tailored PDS and non-tailored PDS
(M = −0.28, 95% CI [−0.22, −0.34]). The non-tailored
PDS group did however, exhibit greater decrease in faecal
aversion than the CG (p = .03).
In addition to treatment effects, there was also a main
effect from FOBT return on the variables salience & co-
herence (F(1,1819) = 8.35, p = .004, η2 = .01) and faecal
aversion (F(1,1819) = 28.2, p = .001, η2 = .02). Those who
screened reported greater improvements in the percep-
tions of screening salience and coherence (M = 0.07,
95% CI [0.04, 0.09]); those who did not return an FOBT
showed little improvement (M = −0.05, 95% CI [−0.13,
0.03]). FOBT returners also showed a greater decrease
in aversion to faecal sampling (M = −0.30, 95% CI
[−0.28, −0.33]) than non-returners (M = 0.01, 95% CI
[−0.09, 0.12]).
There were main effects of Treatment Group (F
(2,1819) = 7.09, p < .001, η2 = .01) and FOBT return (F
(1,1819) = 98.8, p < .001, η2 = .05) on self-efficacy. Partici-
pants in the tailored PDS condition showed significantly
(p = .03) better improvement in self-efficacy (M = 0.17,
















T1 T2 T1 T2 T1 T2 T1 T2 T1 T2 T1 T2 T1 T2
Control M 4.34 4.35 2.80 2.78 2.79 2.73 3.72 3.76 4.01 4.10 2.39 2.21 3.47 3.57
SD 0.53 0.57 1.02 1.07 0.54 0.54 0.59 0.60 0.60 0.64 0.85 0.85 0.77 0.77
CI – Low 4.30 4.30 2.72 2.70 2.75 2.69 3.68 3.72 3.97 4.05 2.32 2.14 3.41 3.51
CI – High 4.38 4.39 2.88 2.86 2.83 2.77 3.77 3.81 4.06 4.15 2.45 2.27 3.53 3.63
Non-Tailored M 4.30 4.35 2.88 2.83 2.87 2.82 3.79 3.78 3.99 4.11 2.45 2.17 3.70 3.67
SD 0.56 0.56 0.99 1.08 0.57 0.60 0.52 0.68 0.54 0.66 0.84 0.85 0.68 0.66
CI – Low 4.26 4.30 2.80 2.74 2.83 2.78 3.75 3.73 3.94 4.06 2.38 2.10 3.65 3.62
CI – High 4.35 4.39 2.96 2.91 2.92 2.87 3.83 3.84 4.03 4.16 2.52 2.24 3.76 3.72
Tailored M 4.25 4.38 2.84 2.77 2.81 2.88 3.74 3.80 3.98 4.15 2.43 2.06 3.65 3.74
SD 0.54 0.55 1.01 1.12 0.53 0.61 0.55 0.68 0.56 0.63 0.82 0.82 0.65 0.65
CI – Low 4.21 4.34 2.76 2.68 2.77 2.83 3.70 3.75 3.93 4.10 2.37 2.00 3.60 3.68
CI – High 4.30 4.43 2.92 2.86 2.85 2.93 3.79 3.86 4.02 4.21 2.50 2.13 3.71 3.79
FOBT Non-Return M 4.22 4.17 2.83 2.98 2.80 2.79 3.74 3.72 3.87 3.55 2.57 2.58 3.47 3.53
SD 0.60 0.56 1.03 1.09 0.52 0.55 0.53 0.64 0.66 0.82 0.90 0.95 0.79 0.69
CI – Low 4.13 4.08 2.66 2.81 2.71 2.71 3.66 3.62 3.77 3.42 2.43 2.43 3.35 3.43
CI – High 4.32 4.26 2.99 3.15 2.88 2.88 3.82 3.82 3.97 3.68 2.71 2.73 3.59 3.64
FOBT Return M 4.31 4.38 2.84 2.77 2.83 2.81 3.75 3.79 4.01 4.18 2.41 2.11 3.62 3.67
SD 0.54 0.56 1.01 1.09 0.55 0.59 0.56 0.66 0.56 0.60 0.83 0.82 0.70 0.70
CI – Low 4.28 4.35 2.79 2.72 2.80 2.78 3.72 3.76 3.98 4.15 2.37 2.07 3.58 3.63
CI – High 4.33 4.40 2.89 2.82 2.85 2.84 3.78 3.82 4.03 4.20 2.45 2.15 3.65 3.70
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95% CI [0.12, 0.22] than CG participants (M = 0.08, 95%
CI [0.03, 0.13]), but they did not show greater change than
non-tailored PDS (M = 0.12, 95% CI [0.07, 0.17], p = .38).
CG and non-tailored PDS groups were not significantly
different (p = .99). Screening participants (M = 0.17,
95% CI [0.14, 0.19]) showed improvement whereas
non-screeners displayed a worsening in their self-efficacy
(M = −0.31, 95% CI [−0.20, −0.43]).
The interaction between treatment condition and FOBT
return was also significant in this model (F(2,1819) = 4.77,
p = .009, η2 = .01). An inspection of the means plot indi-
cated that there was a generally consistent improvement
in self-efficacy in all conditions for FOBT returners (CG:
M = 0.14, 95% CI [0.09, 0.19]; non-tailored PDS: M = 0.17,
95% CI [0.12, 0.22]; tailored PDS: M = 0.21, 95% CI [0.16,
0.26]). By contrast, there was a more marked decrease in
self-efficacy in non-screening non-tailored PDS partici-
pants (NTPDS: M = −0.59, 95% CI [−0.39, −0.79]) com-
pared to the other conditions (CG: M = −0.33, 95% CI
[−0.18, −0.48]; TPDS: M = −0.13, 95% CI [0.03, −0.29]).
Discussion
Initial ITT analyses involving all those randomised, re-
gardless of allocated group or whether they completed a
Baseline Survey (BS) and received an FOBT, indicated
no benefit on screening uptake from exposure to informa-
tion about the importance of bowel cancer screening.
Rates of participation varied little between groups, ranging
between 32.5 and 34.5%, a rate comparable to the 33.5%
most recently reported by the NBCSP for those invited
between 2012 and 2013 [39]. Observed demographic
differences between participants and non-participants
were also largely consistent with those reported by the
national program, although, unlike the NBCSP, neither
gender nor socio-economic disadvantage had a significant
effect on participation. Participation rates increased with
age and differences between states were similar to pub-
lished participation patterns.
By contrast, intervention effects were observed within
the Per Protocol Sample (defined as those who com-
pleted a BS and were mailed an FOBT) in which partici-
pants exposed to online information provision returned
FOBTs at a higher rate than those utilising paper-based
information. This effect was also apparent in the re-
duced Per Protocol sample of individuals who at baseline
were not ready to screen; this analysis excluded individ-
uals who indicated in the baseline survey that they
‘wanted to screen for bowel cancer’. The difference be-
tween the results from the Per Protocol analyses and
those of the ITT analysis suggests that people who
complete a study questionnaire (i.e. the baseline survey)
are in some way different from the broader sample, not-
withstanding their demographic comparability. This dif-
ference may reflect differential engagement with the
topic of bowel cancer screening and this may moderate
the impact of any intervention. More specifically, indi-
viduals may need to have some degree of interest in the
topic in order for an intervention to have an impact on
behaviour.
Despite the contradictory results evidenced in the ITT
and Per Protocol analyses, outcomes from the latter sug-
gest that people in the recommended age group for
screening who were connected to the internet, and who
were prepared to participate in a questionnaire about
bowel cancer, benefited from the provision of advice
about the relevance of screening delivered via the com-
puter. Screening rates varied significantly in the Per
Protocol Sample with screening participation signifi-
cantly higher for those who interacted with the screen-
ing materials online (tailored PDS and non-tailored
PDS) rather than through the usual mail-based delivery
(CG). These results did not, however, support online
message tailoring as a strategy for incremental improve-
ment of participation. Analysis of the impact of demo-
graphic variables on FOBT return highlighted again the
generally positive relationship to age that was consistent
with the ITT result. The only social cognitive variable to
predict return in multivariate analysis of these data was
self–efficacy for screening. This finding is largely consist-
ent with other studies of tailoring including results from
Vernon et al. [19].
The Per Protocol data results were also confirmed in ana-
lyses of intervention effectiveness that utilised only those in
the sample who did not indicate a desire to screen at base-
line, as measured by the PAPM. In this further reduced
sample of people uncommitted to the targeted behaviour at
baseline, provision of information about screening via the
internet led to higher rates of FOBT return. The psycho-
social predictor of FOBT return identified in the full Per
Protocol sample, self-efficacy, was not influential when
committed screeners were removed from the sample.
Instead, salience and coherence of screening and per-
ceived susceptibility to bowel cancer were influential;
uncommitted participants who were more aware of
screening salience and coherence at study start were
more likely to be moved to act, and those with lower
levels of perceived susceptibility at baseline were also
more responsive to the intervention.
Results that analysed changes following the intervention
on social cognitive variables of the Preventive Health
Model and faecal aversion suggest that tailoring may influ-
ence some cognitions about screening. Consistent with
Myers et al’s proposition that messages that improve peo-
ple’s responses to critical social cognitive variables will im-
pact intention and behaviour by moving them to a higher
stage of readiness [22], our results confirm improvement
on self-efficacy was a correlate of movement to action and
improved more in those receiving tailored messages than
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in the control group, although not more than for non-
tailored. Salience and coherence of screening was also
positively impacted by tailored messages. Similarly, tai-
lored internet-based information decreased faecal aversion
more than mailed non-tailored information although not
significantly more than non-tailored, internet-based in-
formation provision. Taken together with the analysis
of non-committed participants, this result highlights
the importance of making information about bowel
cancer screening salient and coherent to potential par-
ticipants, especially those not currently committed to
screening. It is also important to note that failure to
comply with the targeted behaviour (i.e. FOBT return) may
negatively impact self-efficacy to act measured subse-
quently. This possibility is highlighted in the main effect of
FOBT return on changes in self-efficacy. Moreover, the
interaction effect suggests that, for non-participants, an
internet-based, non-tailored message may exacerbate
threats to confidence. An explanation for this would require
further exploration.
There are both strengths and limitations to the
current study. For example, the number of invitations
required to achieve an eligible sample was notably
higher than the initial proposed number (~25,000 ver-
sus 18,000). This was essentially due to a lower uptake
rate for the eligibility phase and also the higher than
expected incidence of self-reported screening in those
who did return the eligibility survey, and these out-
comes have been reported elsewhere [37]. The number
of invitations was increased to ensure that we still re-
cruited sufficient individuals per trial arm as governed
by the power analysis. Despite the fact that there were
significant demographic group differences (residence,
age group, sex) between those who did and did not re-
spond to the invitation, the eligible and randomised
ITT groups were relatively homogenous with regard to
these variables. An additional threat to generalisability
was the study’s focus on internet-enabled participants;
this compromises generalisability to population screen-
ing programs that include individuals who are not ac-
tive internet users. However, this approach was
necessary to ensure that internet access rates did not
confound study results. Whilst a growing segment of
the population within the targeted age-group is using
the internet [40,41], there are still many sub-groups
within the community without ready physical access,
desire or capability to access the internet. Additionally,
the study design, with the incorporation of survey re-
turn as a precondition for FOBT access, provided an
additional hurdle to participation that is not observed
in real-world screening programs. The significance of
this threat is lessened by the observation that partici-
pation rates in the ITT sample were comparable to
that obtained in the NBCSP.
The strength of the study rests with its multiple levels of
analysis—from ITT to Per Protocol to subgroup analysis.
Two of the three levels of analysis suggested that partici-
pation in screening may be enhanced in internet-enabled
people by the use of internet-based communication. The
incorporation of the measurement of change in psycho-
logical constructs provided the opportunity to analyse
how message tailoring and mode of delivery impact upon
attitudes and cognitions with some suggestion that the
benefits of tailoring may accrue at this level. The implica-
tions of this require further examination; changes in the
way people think about screening may impact ongoing
participation.
Conclusions
Internet-based information resources may have a role
in encouraging some sections of the community who
are uncommitted to screening to move along the deci-
sion pathway towards participation. Routine collection
of these data in health practices might facilitate effect-
ive communication. Further research should examine
the potential impact of social cognitive changes on sub-
sequent participation in rescreening. It is possible that
changes on important psycho-social influences on an
intermittent behaviour like participation in biennial
bowel cancer screening enhance perceived importance
of screening and reduce dropouts from screening
programs.
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